Biotech Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Executive Officer August 9, 2022
Biotech Chinook Therapeutics Provides Business Update and Reports Second Quarter 2022 Financial Results August 9, 2022
Biotech Celldex Reports Second Quarter 2022 Financial Results and Provides Corporate Update August 9, 2022
Biotech Vaxcyte Reports Second Quarter 2022 Financial Results and Provides Business Update August 9, 2022
Biotech Prothena Reports Second Quarter 2022 Financial Results and Business Highlights August 9, 2022
Biotech Krystal Biotech Announces Second Quarter 2022 Financial Results and Reports Updates on Operational Progress August 9, 2022
Biotech Bionano Genomics Announces Publication of Landmark Research Study in Myelodysplastic Syndrome Showing OGM Data would Result in Revised Prognostic Risk Classification or Additional Actionable Variants in 28% of Study Participants August 2, 2022
Biotech Krystal Biotech Announces FDA Acceptance of KB407 IND Application for Cystic Fibrosis Clinical Trial August 2, 2022